Wenjie Liu
Shenyang, 110819, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Novel β-Carboline Derivative ZLWH-67 Exerts Potent Anti-MRSA Activity through Multiple Mechanisms.
Journal: ACS infectious diseases
Published: March 06, 2026
Fluorocyclopropyl-Containing Tacrine Derivatives as Potent and Selective Dual CDK2/CDK9 Inhibitors for the Treatment of Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: November 15, 2025
Harmine Derivatives Alleviate LPS-Induced Acute Lung Injury via Targeting GSK3β.
Journal: Inflammation
Published: September 15, 2025
Corrigendum to "Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer" [Eur. J. Med. Chem. 242 (2022): 114701].
Journal: European journal of medicinal chemistry
Published: July 21, 2025
Harmine derivative ZLWH-38 ameliorates the therapeutic efficacy of colistin against XDR-Ab pneumonia by suppressing inflammatory responses.
Journal: International immunopharmacology
Published: June 12, 2025
Design, synthesis, and antitumor activity study of β-carboline derivatives as selective HDAC1/2 inhibitors.
Journal: Bioorganic chemistry
Published: April 24, 2025
UCP1-inspired mitochondrial uncouplers: Design, synthesis and thermogenic activity studies.
Journal: Bioorganic chemistry
Published: December 05, 2024
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's Disease.
Journal: Journal of medicinal chemistry
Published: July 23, 2024
Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatment.
Journal: Archiv der Pharmazie
Published: July 26, 2023
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer.
Journal: European journal of medicinal chemistry
Published: June 29, 2022
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: May 30, 2022
Last Updated: 09/26/2026